← Leaderboards
Stephanie T Page
University Of Washington
$4,517,736
Attributed
$4,749,178
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $790.5K · FY2006–17$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,749,178 · 4
By mechanism
U54$2,097,837 · 1
R01$1,554,496 · 1
K23$633,960 · 1
R21$462,885 · 1
Top collaborators
- Carey Farquhar3 shared
Most similar at University Of Washington
Same institution · by research overlap
- John K Amory$37,632,597
- William J Bremner$7,893,155
- Jay W Heinecke$34,087,651
- Robert Vessella$14,829,966
- Eva Corey$2,497,094
Others in their field
Top investigators on “Androgens”
- Shalendar Bhasin · La Biomed Res Inst/ Harbor Ucla Med Ctr$36,153,267
- Charles L Sawyers · Sloan-Kettering Inst Can Research$24,511,314
- Susan E. Hankinson · University Of Massachusetts Amherst$24,278,267
- Brian E Henderson · University Of Southern California$20,677,861
- Cory Abate-Shen · Columbia University Health Sciences$20,094,849
- Diane E Merry · Thomas Jefferson University$17,810,180
Research focus
AndrogensTestosteronePlacebo Controlled StudyHormonesIncidenceSerumHormonalPlayInflammationIn VivoCholesterolWithdrawalDoseSeveritiesResponseSteroidsPharmaceutical PreparationsMetabolismMaleProteinsBaseAgingGene ExpressionLower Urinary Tract Symptoms
Grant awards (18)
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults$164,735
R21 · FY2017 · TW
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults$124,746
R21 · FY2017 · TW
Male Hormonal Contraception and Metabolic Health$342,134
U54 · FY2016 · HD · contact PI
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults$173,404
R21 · FY2016 · TW
Male Hormonal Contraception and Metabolic Health$354,373
U54 · FY2015 · HD · contact PI
Male Hormonal Contraception and Metabolic Health$482,750
U54 · FY2014 · HD · contact PI
Dose-response relationships between circulating and intraprostatic androgens in m$307,770
R01 · FY2014 · AG · contact PI
Male Hormonal Contraception and Metabolic Health$471,003
U54 · FY2013 · HD · contact PI
Dose-response relationships between circulating and intraprostatic androgens in m$290,337
R01 · FY2013 · AG · contact PI
Male Hormonal Contraception and Metabolic Health$447,577
U54 · FY2012 · HD · contact PI
Dose-response relationships between circulating and intraprostatic androgens in m$312,399
R01 · FY2012 · AG · contact PI
Dose-response relationship between circulating and prostatic androgens in men$324,190
R01 · FY2011 · AG · contact PI
Dose-response relationships between circulating and intraprostatic androgens in m$319,800
R01 · FY2010 · AG · contact PI
Hormonal and molecular consequences of androgen replacement on the prostate$126,792
K23 · FY2010 · AG · contact PI
Hormonal and molecular consequences of androgen replacement on the prostate$126,792
K23 · FY2009 · AG · contact PI
Hormonal and molecular consequences of androgen replacement on the prostate$126,792
K23 · FY2008 · AG · contact PI
Hormonal and molecular consequences of androgen replacement on the prostate$126,792
K23 · FY2007 · AG · contact PI
Hormonal and molecular consequences of androgen replacement on the prostate$126,792
K23 · FY2006 · AG · contact PI